These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 16644400

  • 1. Therapeutic goals in Gaucher disease.
    Mistry P, Germain DP.
    Rev Med Interne; 2006 Mar; 27 Suppl 1():S30-8. PubMed ID: 16644400
    [Abstract] [Full Text] [Related]

  • 2. [Therapeutic objectives in Gaucher disease].
    Mistry P, Germain DP.
    Rev Med Interne; 2007 Oct; 28 Suppl 2():S171-5. PubMed ID: 18228683
    [Abstract] [Full Text] [Related]

  • 3. [Osteoarticular manifestations of Gaucher disease in adults: pathophysiology and treatment].
    Hachulla E, Javier RM.
    Rev Med Interne; 2007 Oct; 28 Suppl 2():S180-2. PubMed ID: 18228685
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical study of the French cohort of Gaucher disease patients].
    Stirnemann J.
    Rev Med Interne; 2006 Mar; 27 Suppl 1():S18-21. PubMed ID: 16644396
    [Abstract] [Full Text] [Related]

  • 5. Treatment of Gaucher's disease with OGT 918.
    Mistry PK.
    Lancet; 2000 Aug 19; 356(9230):676-7. PubMed ID: 10968454
    [No Abstract] [Full Text] [Related]

  • 6. Oral maintenance clinical trial with miglustat for type I Gaucher disease: switch from or combination with intravenous enzyme replacement.
    Elstein D, Dweck A, Attias D, Hadas-Halpern I, Zevin S, Altarescu G, Aerts JF, van Weely S, Zimran A.
    Blood; 2007 Oct 01; 110(7):2296-301. PubMed ID: 17609429
    [Abstract] [Full Text] [Related]

  • 7. Extended remission of B-cell lymphoma with monoclonal gammopathy in a patient with type 1 Gaucher disease treated with enzyme replacement therapy.
    Camou F, Viallard JF.
    Blood Cells Mol Dis; 2012 Jan 15; 48(1):51-2. PubMed ID: 21983348
    [No Abstract] [Full Text] [Related]

  • 8. Outcome of enzyme replacement therapy in patients with Gaucher disease type I. The Romanian experience.
    Grigorescu Sido P, Drugan C, Cret V, Al-Kzouz C, Denes C, Coldea C, Zimmermann A.
    J Inherit Metab Dis; 2007 Oct 15; 30(5):783-9. PubMed ID: 17703370
    [Abstract] [Full Text] [Related]

  • 9. [A retrospective study on enzyme replacement therapy in patients with Gaucher disease].
    Duan YL, Zhang YH, Zang Y, Shi HP, Zhang WM, Hu YM.
    Zhonghua Er Ke Za Zhi; 2006 Sep 15; 44(9):653-6. PubMed ID: 17217655
    [Abstract] [Full Text] [Related]

  • 10. Gaucher disease: hematologic and oncologic implications.
    Hughes D.
    Clin Adv Hematol Oncol; 2011 Oct 15; 9(10):771-2. PubMed ID: 22252578
    [No Abstract] [Full Text] [Related]

  • 11. Gaucher disease: unmet treatment needs.
    Mehta A.
    Acta Paediatr; 2008 Apr 15; 97(457):83-7. PubMed ID: 18339195
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Individualization of long-term enzyme replacement therapy for Gaucher disease.
    Andersson HC, Charrow J, Kaplan P, Mistry P, Pastores GM, Prakash-Cheng A, Rosenbloom BE, Scott CR, Wappner RS, Weinreb NJ, International Collaborative Gaucher Group U.S. Regional Coordinators.
    Genet Med; 2005 Feb 15; 7(2):105-10. PubMed ID: 15714077
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Osteoarticular manifestations of Gaucher disease in adults: pathophysiology and treatment].
    Javier RM, Hachulla E.
    Presse Med; 2007 Dec 15; 36(12 Pt 3):1971-84. PubMed ID: 17498916
    [Abstract] [Full Text] [Related]

  • 16. [Cost reduction in the treatment of Gaucher s disease].
    García Salom P, Acedo A.
    Farm Hosp; 2007 Dec 15; 31(3):194-5. PubMed ID: 17941761
    [No Abstract] [Full Text] [Related]

  • 17. Timing of initiation of enzyme replacement therapy after diagnosis of type 1 Gaucher disease: effect on incidence of avascular necrosis.
    Mistry PK, Deegan P, Vellodi A, Cole JA, Yeh M, Weinreb NJ.
    Br J Haematol; 2009 Nov 15; 147(4):561-70. PubMed ID: 19732054
    [Abstract] [Full Text] [Related]

  • 18. [New data on Gaucher's disease].
    Stirnemann J.
    Rev Med Interne; 2008 Mar 15; 29(3):176-8. PubMed ID: 17964006
    [No Abstract] [Full Text] [Related]

  • 19. Novel heterozygous c.798C>G and c.1040T>G mutations in the GBA1 gene are associated with a severe phenotype of Gaucher disease type 1.
    Machaczka M, Klimkowska M.
    Ann Hematol; 2014 Oct 15; 93(10):1787-9. PubMed ID: 24577513
    [No Abstract] [Full Text] [Related]

  • 20. Imino sugar therapy for type 1 Gaucher disease.
    Priestman DA, Platt FM, Dwek RA, Butters TD.
    Glycobiology; 2000 Nov 15; 10(11):iv-vi. PubMed ID: 11221677
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.